Medicon Hellas
Medicon Hellas (MEDIC) closed at €3.15 on 11/11/2026, +1.61% on the day, on 3.1× its 10-day average volume. Market cap €13.9m, P/E 5.7, dividend yield 4.76%.
MEDIC +23.0% (€2.56 → €3.15) · General Index —
Deepest fall inside it: −8.5% (13 Jul → 22 Jul 2026)
Drag across the chart to measure any stretchSlide sideways across the chart to measure
Key statistics
12 months to Jun 2026 unless a figure says otherwise
Profile
At the 11 Nov close- Market value
- Enterprise valueJun 2026est.
- Shares outstandingJun 2026
- Revenue12 months to Jun 2026
- Employees
- Free floatest.
- Traded a day, 3-month average
Valuation
12 months to Jun 2026- P/E
- P/B
- EV/Salesest.
- EV/EBITDAest.
- P/FCF
- Dividend yield
5 years, on reported full years: 2.2–4.8×, median 3.2×. Today 3.4×, higher than 52% of months.
Margins
12 months to Jun 2026- Gross
- EBITDA
- Operating (EBIT)
- Pre-tax
- Net
- Free cash flow
Net margin = the shareholders' profit ÷ group revenue.
Returns
12 months to Jun 2026- ROE
- ROCE
- ROICest.
- ROAFY2025
- ROE, 5-year averageFY2021–25
- Tax rateFY2025
- Profit to minority holdersFY2025
Financial health
Jun 2026- CashDec 2025
- Net debt
- Net debt ÷ EBITDA
- Interest cover12 months to Jun 2026
Growth
- Revenue, last yearFY2025
- Revenue, last halfH1 2026
- EPS, last yearFY2025
- EPS, last halfH1 2026
- Revenue, 3 yearsFY2022–25, a year
- Revenue, 5 yearsFY2020–25, a year
- EPS, 3 yearsFY2022–25, a year
- Shares, 3 yearsFY2022–25
Dividends
FY2025- Yield, last 12 months
- Per share
- Payout
- Covered by free cash flow
- Years paid, last fiveFY2021–25
Trading and risk
From our closes, dividends reinvested- Total return, 1 year
- +31.2%
- 3 years, a year
- +1.6%
- 5 years, a year
- +4.1%
- 10 years, a year
- +26.2%
- Volatility, 1 year
- 30.6%
- Beta to the General Index
- 0.57×
- Deepest fall, 1 year / 5 years
- −13.1% / −60.5%
- 52-week range
- €2.39–€3.15
Where the figures come from: the company's reports, reviewed by us · annual accounts filed in ESEF format · results announcements on the exchange · our own closing prices. No forecasts or target prices are stored.
Financial charts
From the stored figures: the reviewed dossier first, then the annual reports (ESEF) and results announcements
Loading the charts…
Valuation
no like-for-like peer| Metric | MEDIC |
|---|---|
| P/E | 5.7 |
| P/B | 0.66 |
| P/S | 0.75 |
| EV/EBITDA | 2.5 |
| Dividend yield | 4.8% |
| Payout ratio | 38.3% |
| Gross margin | 73.2% |
| Operating margin | 16.5% |
| Net margin | 13.2% |
| ROE | 11.7% |
| Revenue growth (last full year) | −0.9% |
| Net debt | −€2.8m |
Peers: Diagnostics
No other company listed in Athens runs this business; related ones can be ticked in.
The company
AI-draftedMakes in-vitro diagnostic reagents in Gerakas, distributes foreign analysers and reagents, and runs three private diagnostic laboratories (Megalab). Customers are mainly public hospitals and insurance funds in Greece, with exports accounting for 20.2% of H1 2026 sales.
- Sep 2026H1 2026 results: revenue €9.52m (+7.6%), owners' profit €1.52m against €0.79m.2
- Jul 2026The €0.15 FY2025 dividend per share, payable from 17 July.5
- Jun 2026The AGM re-elects the seven-member board for six years, four of them independent.7,8
- Apr 2026FY2025 results: profit after tax up 32.6% to €1.77m.4
- Jul 2025Payment of the €0.13 FY2024 dividend per share, from 11 July.6
- Jul 2024Sale of the 50.90% stake in Pliroforiki Ellados to IKnowHealth for €356,291.9,3
- In H1 2026 own-made products generated 48.41% of sales, merchandise 38.32% and services 13.27%.2
- June 2026 hospitals and EFKA owed €6.803m of the €7.885m gross balances in the receivables ageing table; H1 collection time was 153 days.2
- In H1 2026 revenue rose 7.6% and EBITDA 47%.2
- A €0.15 dividend with payment starting 17 July 2026 and 5% withholding tax.5
- The historical restructuring agreements specify about €5.1m of final instalments on 31 December 2027. June 2026 cash and deposits totalled €11.7m; the interim confirms compliance without restating those instalments.10,11,2
- 1.Annual report 2025Medicon Hellas S.A. · 30/04/2026official
- 2.Half-year report 2026Medicon Hellas S.A. · 30/09/2026official
- 3.Annual report 2024Medicon Hellas S.A. · 25/04/2025official
- 4.Results announcement FY2025Medicon Hellas S.A. · 30/04/2026official
- 5.Dividend FY2025 noticeMedicon Hellas S.A. · 30/06/2026official
- 6.Dividend FY2024 noticeMedicon Hellas S.A. · 26/06/2025official
- 7.AGM decisions 30 June 2026Medicon Hellas S.A. · 30/06/2026official
- 8.Board and committees 30 June 2026Medicon Hellas S.A. · 30/06/2026official
- 9.Sale of 50.90% of Pliroforiki ElladosMedicon Hellas S.A. · 12/07/2024official
- 10.Annual report 2018Medicon Hellas S.A. · 18/04/2019official
- 11.Annual report 2019Medicon Hellas S.A. · 18/06/2020official